Capital Management Associates Inc’s AbbVie ABBV Stock Holding History

Capital Management Associates Inc’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$215K	Buy	+853	New	+$184K	0.04%	148
2026 Q1	–	Sell	-1,315	Closed	-$301K	–	152
2025 Q4	$301K	Hold	1,315	–	–	0.07%	121
2025 Q3	$305K	Buy	+1,315	New	+$268K	0.08%	108
2025 Q2	–	Sell	-1,540	Closed	-$323K	–	117
2025 Q1	$323K	Buy	+1,540	New	+$299K	0.07%	99

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Capital Management Associates Inc's ABBV Position: Q2 2026 in Review

Capital Management Associates Inc opened a new position in AbbVie (ABBV) in Q2 2026: 853 shares worth $215K. The stake represents 0.04% of the portfolio and ranks #148 among its holdings. This is a return to the name: Capital Management Associates Inc previously reported a position in ABBV as recently as Q4 2025.

Capital Management Associates Inc first reported a position in ABBV in Q1 2025 and has held it in 4 quarters since. The position peaked at $323K in Q1 2025. 1,316 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Capital Management Associates Inc held 853 shares of AbbVie worth $215K as of Q2 2026.
AbbVie was a new Capital Management Associates Inc position in Q2 2026.
AbbVie made up 0.04% of Capital Management Associates Inc's portfolio in Q2 2026, its #148 holding.
Capital Management Associates Inc first reported a position in AbbVie in Q1 2025 and has held it in 4 quarters since.
Capital Management Associates Inc's AbbVie position peaked at $323K in Q1 2025.
1,316 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Capital Management Associates Inc's 13F filing for Q2 2026, filed 22 Jul 2026.